DUSPATALIN RETARD CAPSULE 200mg

Product Information

Registration Status: Active

DUSPATALIN RETARD CAPSULE 200mg is approved to be sold in Singapore with effective from 1994-10-03. It is marketed by ABBOTT LABORATORIES (SINGAPORE ) PTE LTD, with the registration number of SIN07666P.

This product contains Mebeverine 200mg in the form of CAPSULE. It is approved for ORAL use.

This product is manufactured by ABBOTT BIOLOGICALS B.V. in FRANCE, andMylan Laboratories SAS in NETHERLANDS.

It is a Pharmacy Only Medicine that can be obtained from a pharmacist at a retail pharmacy.

Mebeverine

Description

Mebeverine has been investigated for the treatment of Irritable Bowel Syndrome and Post-cholecystectomy Gastrointestinal Spasms.

Active Ingredient/Synonyms

Mebeverine | Mebeverine |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank